Will knowledge of the molecular pathology of lymphoma improve clinical trials?
David Maloney et al.
Double-blind trial of denosumab vs. zoledronic acid for bone disease in NDMM
Evangelos Terpos • 5 Oct 2018
iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine
Anas Younes et al. • 22 Sep 2018